Zacks Research Estimates Integer’s Q1 Earnings (NYSE:ITGR)

Integer Holdings Corporation (NYSE:ITGR) – Equities research analysts at Zacks Research decreased their Q1 2026 earnings per share estimates for shares of Integer in a research report issued to clients and investors on Wednesday, March 11th. Zacks Research analyst Team now forecasts that the medical equipment provider will earn $1.31 per share for the quarter, down from their prior estimate of $1.39. The consensus estimate for Integer’s current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Integer’s Q2 2026 earnings at $1.57 EPS, Q3 2026 earnings at $1.73 EPS, Q4 2026 earnings at $1.79 EPS, FY2026 earnings at $6.40 EPS, Q1 2027 earnings at $1.51 EPS, Q3 2027 earnings at $1.88 EPS, Q4 2027 earnings at $1.86 EPS, FY2027 earnings at $6.95 EPS and FY2028 earnings at $7.57 EPS.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.06. The company had revenue of $472.06 million for the quarter, compared to analyst estimates of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.The company’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.43 earnings per share. Integer has set its FY 2026 guidance at 6.290-6.780 EPS.

ITGR has been the subject of a number of other research reports. Raymond James Financial reaffirmed an “outperform” rating and set a $101.00 price target on shares of Integer in a research report on Monday, February 23rd. Wells Fargo & Company lifted their price objective on shares of Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, February 20th. Wall Street Zen lowered shares of Integer from a “buy” rating to a “hold” rating in a research report on Sunday, January 25th. Truist Financial raised their target price on shares of Integer from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Friday, February 20th. Finally, Weiss Ratings upgraded shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 24th. Four research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $102.00.

Integer Stock Up 2.6%

Shares of Integer stock opened at $85.48 on Thursday. The business’s 50 day simple moving average is $85.01 and its 200 day simple moving average is $86.20. Integer has a 52-week low of $62.00 and a 52-week high of $127.56. The firm has a market cap of $2.94 billion, a PE ratio of 29.78, a P/E/G ratio of 1.42 and a beta of 0.75. The company has a debt-to-equity ratio of 0.69, a quick ratio of 2.23 and a current ratio of 3.32.

Institutional Investors Weigh In On Integer

Several large investors have recently made changes to their positions in ITGR. Tudor Investment Corp ET AL grew its stake in shares of Integer by 50,787.5% in the third quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock valued at $28,606,000 after buying an additional 29,442,029 shares in the last quarter. Vanguard Group Inc. increased its holdings in Integer by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 3,886,150 shares of the medical equipment provider’s stock worth $304,791,000 after buying an additional 14,465 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Integer by 4.9% during the third quarter. Dimensional Fund Advisors LP now owns 1,410,480 shares of the medical equipment provider’s stock worth $145,738,000 after acquiring an additional 65,865 shares in the last quarter. State Street Corp lifted its stake in Integer by 3.7% in the fourth quarter. State Street Corp now owns 1,371,767 shares of the medical equipment provider’s stock valued at $107,588,000 after acquiring an additional 48,463 shares during the last quarter. Finally, Viking Global Investors LP lifted its stake in Integer by 9.1% in the second quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock valued at $157,889,000 after acquiring an additional 106,692 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.